Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WALMART INC.

(WMT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

A $10 Covid-19 Test? Walmart Heirs Back Startup Developing At-Home Tests

11/20/2020 | 05:58pm EDT

By Sarah Nassauer and Sarah Krouse

The billionaire Walton family that controls Walmart Inc. is among a group of investors backing a startup aiming to design at-home Covid-19 tests to sell for as little as $10 at the retail giant's stores and elsewhere.

NowDiagnostics Inc., based 20 miles south of Walmart's corporate headquarters, has filed requests for emergency authorization from the U.S. Food and Drug Administration for a Covid-19 antibody blood test, according to the Springdale, Ark., company.

It is also developing two at-home Covid-19 tests that would use a patient's salvia and deliver results in minutes, said Chief Executive Kevin Clark. One of those would be an antigen test that looks for virus proteins to diagnose an active infection and the other an antibody test, which looks for an immune response that can signal a previous infection.

None of the tests have been authorized by the FDA for use.

For several years Walmart has talked with NowDiagnostics about selling tests for ailments like the flu in its stores, as part of a push to offer more fixed-priced health-care services and products. Those discussions expanded during the pandemic to include Covid-19 diagnostic and serologic tests if they pass regulatory muster, people familiar with the discussions said.

NowDiagnostics is one of many biotechnology and diagnostic companies racing to develop easy-to-use at-home tests for Covid-19. To date, those tests have faced hurdles including ensuring users know how to collect high-quality samples and process them in a way that delivers accurate results.

While saliva samples are used for diagnostic PCR tests run in labs, and collecting spit is less invasive than swabbing a person's nose or throat, no saliva-based rapid tests have yet secured emergency approval. OraSure Technologies Inc., which has tried to create a saliva-based rapid antigen test, recently abandoned the development work.

"As research and development progressed, we found we could achieve greater sensitivity, and the best possible accuracy, by using samples collected with a simple, fast swab just inside of the nostril," said Dr. Stephen Tang, OraSure's chief executive.

The FDA this week approved the first at-home Covid-19 test that includes a nasal swab people can administer themselves and receive results in minutes. The company that makes the tests, Lucira Health Inc., said it plans to roll them out nationally by spring, likely costing about $50 apiece. Lucira plans to eventually sell its test online and deliver it overnight with a medical professional's prescription.

NowDiagnostics aims to sell each of its three Covid-19 tests for under $10, said Mr. Clark.

Investors in NowDiagnostics include members of the Walton family through Arkansas-based venture capital firm NewRoad Capital Partners, according to people familiar with the matter. NowDiagnostics investors also include several former Walmart executives, said these people.

A spokeswoman for the Walton family declined to comment. Mr. Clark declined to discuss the Waltons, saying the company has investors from across the country. NewRoad declined to comment on individual investors.

For years NowDiagnostic has worked to develop inexpensive at-home medical tests including for HIV, pregnancy and food intolerance, but it shifted focus to develop Covid-19-related products when the pandemic hit, said Mr. Clark. The company's blood-based pregnancy test for lab use is the only one that has been cleared by the FDA, he said.

Walmart isn't directly involved with NowDiagnostics and doesn't have an exclusive agreement to buy its products, said Mr. Clark, but the company has worked closely with current and former Walmart executives.

"This concept began out of some conversation with Walmart personnel, way back in 2012," he said.

A Walmart spokeswoman declined to comment.

In recent years Walmart has worked to broaden its health-care business, mostly by offering medical treatments at upfront low prices, often below the cost of an insurance copay. It has built a handful of clinics near or inside Walmart stores that offer doctor's visits, X-rays and dental services. Executives said during recent investor presentations that they plan to build more.

Walmart has hundreds of stores that offer Covid-19 testing from pharmacy windows or parking lots, in partnership with federal and state governments, labs and insurance companies. Those sites currently send samples to lab companies like Quest Diagnostics Inc. and eTrueNorth for processing.

The Walton family collectively owns around 50% of Walmart's stock, and three family members currently sit on the Walmart board. The family has invested previously in other upstart diagnostic companies including blood-testing company Theranos Inc. They were among the many investors burned by the startup when it dissolved after being accused of defrauding doctors, patients and its backers.

Write to Sarah Nassauer at sarah.nassauer@wsj.com and Sarah Krouse at sarah.krouse@wsj.com

(END) Dow Jones Newswires

11-20-20 1758ET

Stocks mentioned in the article
ChangeLast1st jan.
APTIV PLC -0.52% 140.32 Delayed Quote.7.70%
ORASURE TECHNOLOGIES, INC. -5.09% 9.5 Delayed Quote.-10.25%
QUEST DIAGNOSTICS INCORPORATED 0.75% 131.09 Delayed Quote.10.00%
WALMART INC. -0.64% 139.71 Delayed Quote.-3.08%
All news about WALMART INC.
04/19Union Appeals Amazon Election in Alabama, Says Company Violated Laws
DJ
04/19WALMART  : Offers BinaxNOW COVID-19 Antigen Self Test
MT
04/19WALMART  : One Year Later, Testing Remains Important
BU
04/19GameStop loses CEO in latest management shakeup
RE
04/19Union Appeals Amazon Election in Alabama, Says Company Violated Laws -- Updat..
DJ
04/19SLEEP COUNTRY CANADA  : Upgraded to Outperformer at CIBC
MT
04/18Supermarkets' Revival Skips the Top Store-Brand Supplier
DJ
04/16BIDEN WHITE HOUSE'S SECRET WEAPON ON : small businesses
RE
04/15GENERAL MOTORS  : Backed Self-Driving Automaker Cruise Raises $2.75 Billion From..
MT
04/15WALMART  : Invests in Cruise, the All-Electric Self-Driving Company
PU
More news
Financials (USD)
Sales 2022 547 B - -
Net income 2022 15 065 M - -
Net Debt 2022 33 389 M - -
P/E ratio 2022 26,1x
Yield 2022 1,57%
Capitalization 394 B 394 B -
EV / Sales 2022 0,78x
EV / Sales 2023 0,75x
Nbr of Employees 2 300 000
Free-Float 2,07%
Chart WALMART INC.
Duration : Period :
Walmart Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALMART INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 38
Average target price 159,06 $
Last Close Price 139,71 $
Spread / Highest target 28,8%
Spread / Average Target 13,9%
Spread / Lowest Target -14,1%
EPS Revisions
Managers and Directors
NameTitle
C. Douglas McMillon President, Chief Executive Officer & Director
Brett M. Biggs Chief Financial Officer & Executive Vice President
Gregory B. Penner Non-Executive Chairman
Clay Johnson Enterprise Chief Information Officer & EVP
Jerry R. Geisler Chief Information Security Officer & Senior VP
Sector and Competitors
1st jan.Capitalization (M$)
WALMART INC.-3.08%393 573
SEVEN & I HOLDINGS CO., LTD.23.97%36 891
ALIMENTATION COUCHE-TARD INC.-4.40%35 971
AVENUE SUPERMARTS LIMITED5.66%25 381
SM INVESTMENTS CORPORATION-7.05%24 348
COLES GROUP LIMITED-14.72%16 049